(go to content)

Castellano | Euskara | Français | English

 Imagen decorativa
DAR No 5. Dronedarone (Multaq®) for non-permanent atrial fibrillation

Content tools

Share it

  • Meneame
  • Delicious
  • Twitter
  • Google
  • Facebook

Lower efficacy than amiodarone and a questionable safety profile

  • Dronedarone is less effective than amiodarone in preventing recurrent episodes of atrial fibrillation.
  • Its safety profile is far from established. An increase in mortality in patients with heart failure and a warning of hepatic abnormalities have been published.
  • Although it does not produce thyroid disorders like amiodarone, on a whole it has not been shown to be more effective.
  • The potential for interactions is even more complex than amiodarone.
  • In addition to this data, the price of dronedarone is ten times higher than that of amiodarone.
Enviar comentario

You can send us a comment or suggestion and we will respond to most frequently asked questions

Competing interests (complete this field only if you have competing interests)






Government of Navarre

Contact us | Accessibility | Legal notice | Site map